Bacterial Infections And Mycoses clinical trials

Explore recruiting bacterial infections and mycoses clinical trials.

Recruiting bacterial infections and mycoses studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bacterial Infections And Mycoses trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A pHase III cluster randomIsed controlled, cross-over, non-inferiority Trial of a short course, High dose AntimicRobials vs conventional dose and Duration in critically ill patients

Netherlands, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, Phase I, single-center, observer-blind, active-controlled study to evaluate the safety, tolerability and immunogenicity of one single administration of PCV-LITE, a novel adjuvanted pneumococcal conjugate vaccine at one dose level of LiteVax Adjuvant, in healthy participants aged 18-50 years.

Belgium

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Effects of mesenchymal stem cells administration on organ failure during septic shock: Phase II randomized comprator-controlled study CHOC-MSC

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older

Belgium, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

KISS Evaluation of early administration of Levetiracetam in the prevention and treatment of delirium during septic shock: a randomized, double-blind, placebo-controlled trial.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized, Double Blind, Placebo Controlled "first-in-human" Study to Assess the Safety and Tolerability of Single Ascending Intravenous Doses and Multiple Intravenous Doses of RA0127 in Healthy Young Volunteers

Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Bacterial Infections And Mycoses trials by city

Bacterial Infections And Mycoses in Toronto Bacterial Infections And Mycoses in Vancouver Bacterial Infections And Mycoses in Montreal Bacterial Infections And Mycoses in Calgary Bacterial Infections And Mycoses in Edmonton Bacterial Infections And Mycoses in Ottawa Bacterial Infections And Mycoses in Winnipeg Bacterial Infections And Mycoses in Quebec City Bacterial Infections And Mycoses in Hamilton Bacterial Infections And Mycoses in Kitchener Bacterial Infections And Mycoses in London Bacterial Infections And Mycoses in Halifax Bacterial Infections And Mycoses in New York Bacterial Infections And Mycoses in Los Angeles Bacterial Infections And Mycoses in Chicago Bacterial Infections And Mycoses in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease